Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis.

BACKGROUND According to current guidelines the cost of productivity loss should be considered in pharmacoeconomic analyses. The cost of health-related productivity loss in psoriasis patients is unknown. OBJECTIVE To estimate the cost of productivity loss in psoriasis and its association with health-related quality of life and clinical disease severity… CONTINUE READING